XENE Equity Ratio

Xenon Pharmaceuticals Inc · Equity Ratio

XENE logo

XENE Equity Ratio

Current (TTM)95.88%
XENE Equity Ratio (19.94% → 95.88%)
High-resolution chart · PNG

XENE equity ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Xenon Pharmaceuticals Inc Equity Ratio — Annual fiscal periods
Period endingEquity Ratio
59.2622%
94.5829%
96.1777%
95.6707%
96.1584%
90.5749%
62.2741%
84.372%
77.9124%
94.6864%
95.4417%
83.254%
44.2601%
19.94%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.